Forte Biosciences Q3 EPS $(0.26) Down From $(0.18) YoY
Portfolio Pulse from Benzinga Newsdesk
Forte Biosciences (NASDAQ:FBRX) reported a 44.44% increase in losses in Q3 with EPS at $(0.26), down from $(0.18) in the same period last year.
November 13, 2023 | 10:04 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Forte Biosciences reported a significant increase in quarterly losses, with EPS worsening to $(0.26) from $(0.18) year-over-year.
The reported increase in losses for Forte Biosciences is a negative indicator for the company's financial performance and is likely to be viewed unfavorably by investors, potentially leading to a short-term decline in the stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100